rheumatologylinx Medical News

Click the title below to leave the MDLinx Network and go to the Journal's Website

Efficacy and tolerability of urate lowering drugs in gout
Annals of Rheumatic Diseases, 04/29/08

Email This Article

Save in My Library

Free Abstract

Reinders MK et al. - This study demonstrates a poor efficacy and tolerability profile of allopurinol 300 mg/day to attain a biochemical predefined target level of sUr 0.30 mmol/l after 2-months treatment. In stage 2, benzbromarone 200 mg/day is more effective and better tolerated than probenecid 2000 mg/day.

--- CLINICAL PHARMACOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Rapid correction of low vitamin D status in nursing home residents
Osteoporosis International, 05/22/08

Risk of hip fracture after bisphosphonate discontinuation: Implications for a drug holiday
Osteoporosis International, 05/21/08

Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: Diagnostic and therapeutic strategies.
Current Opinion in Rheumatology, 06/10/08

...All of Clinical Pharmacology

Sponsor

--- GOUT AND HYPERURICEMIA TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Measuring Quality of Care for Rheumatic Diseases Using an Electronic Medical Record
Annals of Rheumatic Diseases, 06/11/08

Use of oral prednisolone or naproxen for the treatment of gout arthritis: A double-blind, randomised equivalence trial
The Lancet, 06/09/08

Systemic corticosteroids for acute gout
Cochrane Reviews, 04/18/08

...All of Gout and Hyperuricemia